Table 2.
Comparison of common adverse reactions between PLI+RFA group and PEI+RFA group [n (%)]
| Adverse Effect | PLI+RFA group (n=24) | PEI+RFA group (n=17) | ||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
||||||
| Any grade (%) | Grade 3 (%) | Any grade (%) | Grade 3 (%) | Any grade (%) | Grade 3 (%) | |||
|
|
|
|||||||
| χ2 | P | χ2 | P | |||||
| Abdominal pain | 18 (75) | 2 (8.3) | 11 (64.7) | 1 (5.9) | 0.509 | 0.507 | 0.088 | 1.000 |
| Fatigue | 18 (75) | 0 | 14 (82.4) | 0 | 0.314 | 0.711 | ||
| Nausea | 17 (70.8) | 0 | 11 (64.7) | 0 | 0.173 | 0.678 | ||
| Vomiting | 12 (50) | 0 | 9 (52.9) | 0 | 0.035 | 0.853 | ||
| Fever | 21 (87.5) | 0 | 15 (88.2) | 0 | 0.005 | 1.000 | ||
| ALT elevation | 22 (91.7) | 6 (25) | 14 (82.4) | 3 (17.7) | 0.806 | 0.633 | 0.314 | 0.711 |
| AST elevation | 20 (83.3) | 4 (16.7) | 12 (70.6) | 2 (11.8) | 0.944 | 0.450 | 0.191 | 1.000 |
| Bilirubin elevation | 10 (41.7) | 0 | 7 (41.2) | 0 | 0.001 | 0.975 | ||
Note: ALT: alanine aminotransferase; AST: aspartate aminotransferase.